Renin-angiotensin system gene polymorphisms and atrial fibrillation: A regression approach for the detection of gene-gene interactions in a large hospitalized population

Cardiology

Volumn 111, Issue 1, 2008, Pages 1-7

  Tsai, Chia Ti ^a   Hwang, Juey Jen ^a   Chiang, Fu Tien ^a   Wang, Yi Chih ^a   Tseng, Chuen Den ^a   Tseng, Yung Zu ^a   Lin, Jiunn Lee ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Angiotensinogen; Atrial fibrillation; Haplotype; Multilocus; Regression; Renin angiotensin system

Indexed keywords

AGED; ARTICLE; CARDIAC PATIENT; FEMALE; GENE FREQUENCY; GENE INTERACTION; GENE LOCUS; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REGRESSION ANALYSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; SCORING SYSTEM; SINUS RHYTHM; STATISTICAL MODEL;

AGED; AGED, 80 AND OVER; ANGIOTENSINOGEN; ATRIAL FIBRILLATION; FEMALE; HAPLOTYPES; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MULTIFACTORIAL INHERITANCE; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RECEPTOR, ANGIOTENSIN, TYPE 1;

EID: 46849102209     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000113419     Document Type: Article

References (28)

1. Brilla CG, Pick R, Tan LB, Janicki JS, Weber KT: Remodeling of the rat right and left ventricles in experimental hypertension. Circ Res 1990;67:1355-1364.
2. Weber TK, Brilla CG, Janicki JS: Myocardial fibrosis: functional significance and regulatory factors. Cardiovasc Res 1993;27:341-348.
3. Hanatani A, Yoshiyama M, Kim S, Omura T, Toda I, Akioka K, Teragaki M, Takeuchi K, Iwao H, Takeda T: Inhibition by angiotensin II type I receptor antagonist of cardiac phenotypic modulation after myocardial infarction. J Mol Cell Cardiol 1995;27:1905-1914.
4. Urata H, Boehm KD, Philip A, Kinoshita A, Gabrovsek J, Bumpus FM, Husain A: Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart. J Clin Invest 1993;91:1269-1281.
5. Goette A, Staack T, Rocken C, Arndt M, Geller JC, Huth C, Ansorge S, Klein HU, Lendeckel U: Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation. J Am Coll Cardiol 2000;35:1669-1677.
6. Li D, Shinagawa K, Pang L, Leung TK, Cardin S, Wang Z, Nattel S: Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure. Circulation 2001;104:2608-2614.
7. Komuro I, Kaida T, Shibazaki Y, Kurabayashi M, Katoh Y, Hoh E, Takaku F: Stretching cardiac myocytes stimulates proto-oncogene expression. J Biol Chem 1990;265:3595-3598.
8. Nakashima H, Kumagai K, Urata H, Gondo N, Ideishi M, Arakawa K: Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation. Circulation 2000;101:2612-2617.
9. Pedersen OD, Bagger H, Kober L, Torp-Pedersen C: Trandolapril reduces the incidence of atrial fibrillation after myocardial infarction in patients with left ventricular dysfunction. Circulation 1999;100:376-380.
10. Van Den Berg MP, Crijns HJ, Van Veldhuisen DJ, Griep N, De Kam PJ, Lie KI: Effects of lisinopril in patients with heart failure and chronic atrial fibrillation. J Card Fail 1995;1:355-364.
11. Madrid AH, Bueno MG, Rebollo JM, Marin I, Pena G, Bernal E, Rodriguez A, Cano L, Cano JM, Cabeza P, Moro C: Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study. Circulation 2002;106:331-336.
12. Ellinor PT, Shin JT, Moore RK, Yoerger DM, MacRae CA: Locus for atrial fibrillation maps to chromosome 6q14-16. Circulation 2003;107:2880-2883.
13. Chen YH, Xu SJ, Bendahhou S, Wang XL, Wang Y, Xu WY, Jin HW, Sun H, Su XY, Zhuang QN, Yang YQ, Li YB, Liu Y, Xu HJ, Li XF, Ma N, Mou CP, Chen Z, Barhanin J, Huang W: KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science 2003;299:251-254.
14. Brugada R, Tapscott T, Czernuszewicz GZ, Marian AJ, Iglesias A, Mont L, Brugada J, Girona J, Domingo A, Bachinski LL, Roberts R: Identification of a genetic locus for familial atrial fibrillation. N Engl J Med 1997;336:905-911.
15. Tsai CT, Lai LP, Lin JL, Chiang FT, Hwang JJ, Ritchie MD, Moore JH, Hsu KL, Tseng CD, Liau CS, Tseng YZ: Renin-angiotensin system gene polymorphisms and atrial fibrillation. Circulation 2004;109:1640-1646.
16. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA: Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 2002;70:425-434.
17. Lake SL, Lyon H, Tantisira K, Silverman EK, Weiss ST, Laird NM, Schaid DJ: Estimation and tests of haplotype-environment interaction when linkage phase is ambiguous. Hum Hered 2003;55:56-65.
18. Sahn DJ, DeMaria A, Kisslo J, Weyman A: Recommendations regarding quantification in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58:1072-1083.
19. Lahri DK, Nurnberger JI Jr: A rapid nonenzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acid Res 1991;19:5444.
20. Chiang FT, Hsu KL, Chen WM, Tseng CD, Tseng YZ: Determination of angiotensin-converting enzyme gene polymorphism: stepdown PCR increases detection of heterozygotes. Clin Chem 1998;44:1353-1356.
21. Chiang FT, Hsu KL, Tseng CD, Hsiao WH, Lo HM, Chern TH, Tseng YZ: Molecular variant of M235T of the angiotensinogen gene is associated with essential hypertension in Taiwanese. J Hypertens 1997;15:607-611.
22. Hilgers KF, Langenfeld MR, Schlaich M, Veelken R, Schmieder RE: 1166 A/C polymorphism of the angiotensin II type 1 receptor gene and the response to short-term infusion of angiotensin II. Circulation 1999;100:1394-1399.
23. Yanai K, Saito T, Hirota K, Kobayashi H, Murakami K, Fukamizu A: Molecular variation of the human angiotensinogen core promoter element located between TATA box and transcriptional initiation site affects its transcriptional activity. J Biol Chem 1997;272:30558-30562.
24. Inoue I, Nakajima T, Williams CS, Quackenbush J, Puryear R, Powers M, Cheng T, Ludwig EH, Sharma AM, Hata A, Jeunemaitre X, Lalouel JM: A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest 1997;99:1786-1797.
25. Zhao YY, Zhou J, Narayanan CS, Cui Y, Kumar A: Role of C/A polymorphism at -20 on the expression of human angiotensinogen gene. Hypertension 1999;33:108-115.
26. Wu SJ, Chiang FT, Jiang JR, Hsu KL, Chern TH, Tseng YZ: The G-217A variant of angiotensinogen gene affects basal transcription and is associated with hypertension in a Taiwanese population. J Hypertens 2003;21:2061-2067.
27. Tsai CT, Fallin D, Chiang FT, Hwang JJ, Lai LP, Hsu KL, Tseng CD, Liau CS, Tseng YZ: Angiotensinogen gene haplotype and hypertension: interaction with ACE gene I allele. Hypertension 2003;41:9-15.
28. Martin ER, Lai EH, Gilbert JR, Rogala AR, Afshari AJ, Riley J, Finch KL, Stevens JF, Livak KJ, Slotterbeck BD, Slifer SH, Warren LL, Conneally PM, Schmechel DE, Purvis I, Pericak-Vance MA, Roses AD, Vance JM: SNPing away at complex disease: analysis of singe-nucleotide polymorphisms around APOE in Alzheimer disease. Am J Hum Genet 2000;67:383-394.